Wilmington, Delaware, United States, Aug. 18, 2022 (GLOBE NEWSWIRE) — Transparency Market Research Inc. – The value of the global hospital acquired disease testing market size stood at US$ 798.6 Mn in 2018. The hospital acquired disease testing market analysis expects the market to develop at a CAGR of 14.7% during the forecast period, from 2019 to 2027. Hospital acquired disease testing market to reach US$ 2.85 Bn by 2027. The global market is projected to be driven by an increase in the number of pathogens with drug resistance and incidence of hospital acquired infections. Development of government policies and guidelines for prevention and management of hospital acquired infections is also anticipated to propel the global market for testing for hospital acquired infections during the given timeframe.
Cost of hospital acquired infection prevention ranges between $28.0 billion and $33 billion annually, as reported by the U.S. Department of Health and Human Services. Governments are implementing steps to lower the occurrence of hospital acquired infections in the respective countries to lessen the strain on hospitals caused by patients’ prolonged hospital stays. Increasing involvement is governments is likely to emerge as an important hospital acquired disease testing market trends.
Bodies for hospital acquired infection prevention and control exist in developed nations, and they have created standards for the identification and management of hospital acquired infections. For instance, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) suggests a two-step detection technique for the detection of Clostridium difficile, but the Centers for Disease Control and Prevention (CDC) advises a nucleic acid amplification test. In nations where the legal as well as regulatory frameworks have been developed and are being adhered to, these rules are what drive the demand for recommended testing.
Get Exclusive PDF Sample Copy of Hospital Acquired Disease Testing Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1759
Key Findings of Market Report
- Public awareness campaigns by government and organizations in charge of preventing these infections emphasize the need for testing for hospital acquired infections as well as the available treatments. Such awareness raising programs are Ongoing trends of the hospital acquired disease testing market and is expected to boost demand in the years to come.
- North America is expected to account for s substantial hospital acquired disease testing market share. This dominance is likely to persist throughout the forecast period.
Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=1759
Global Hospital Acquired Disease Testing Market: Key Players
Some of the key market players are
- Thermo Fisher Scientific, Inc.
- Diatherix Laboratories, Inc.
- Becton Dickinson and Company
- Hoffmann-La Roche Ltd
- Meridian Bioscience, Inc.
- bioMérieux SA
Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1759
Global Hospital Acquired Disease Testing Market: Segmentation
- Urinary Tract
- Surgical Site
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:
Orthobiologics Market: The global orthobiologics market is anticipated to reach more than US$ 7.4 Bn by the end of 2031 with CAGR of 4.7% from 2022 to 2031.
Atrial Fibrillation Market: The global atrial fibrillation market is anticipated to exceed value of US$ 18.5 Bn by 2031 with a CAGR of 6% from 2022 to 2031.
Ostomy Drainage Bags Market: The global ostomy drainage bags market is expected to cross value of US$ 3.6 Bn by the end of 2031 with a CAGR of 5.4% from 2022 to 2031.
Wound Debridement Market: The wound debridement (wound cleaning) market was valued at US$ 1,964.5 Mn in 2018 and is anticipated to expand at a CAGR of 6.1 % from 2019 to 2027.
Wound Closure Strips Market: The global wound closure strips market was valued at US$ 250 Mn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027.
Advanced Wound Care Management Market: The global advanced wound care management market was valued at US$ 8,531.0 Mn in 2017 and is anticipated to expand at a CAGR of 5.8 % from 2018 to 2026.
Wound Healing Market: The global wound healing market is expected to reach a value of US$35,065.7 mn by the end of 2025. The market is predicted to register a healthy 4.80% CAGR between 2017 and 2025.
Diagnostic Reagents Market: The global diagnostic reagents market is anticipated to reach more than US$ 85.8 Bn by the end of 2031. The global market is projected to grow at a CAGR of 6.5% from 2022 to 2031.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update – https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
USA – Canada Toll Free: 866-552-3453